- Tidingo.com

ArGentis Receives Favorable Opinion For European Orphan Drug Designation

arGentis Pharmaceuticals, LLC announced that the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) adopted a positive opinion recommending the company's product candidate ARG201 (native type 1 bovine collagen) for the treatment of diffuse systemic sclerosis, also known

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

Cytori Expands Patent Protection For Celution(R) Stem & Regenerative Cell Processing System

Cytori (NASDAQ: CYTX) received U.S. Patent No. 7,473,420 (the '420 patent), which protects important formulations of the Celution® System output. This builds upon U.S. Patent No. 7,390,484, issued to Cytori in June 2008, which covers the Celution System technology for the bedside processing of stem and regenerative cells derived from adipose tissue.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

Genetics For The Public: First Annual Consumer Genetics Show In Boston June 9 -11, 2009

Show The First Annual Consumer Genetics announced that it will open its exhibit hall to the general public. The first conference of its kind, it will showcase both genetic testing companies offering a wide variety of products, as well as the genetic tool companies that enable the science in this emerging health care specialty.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

KYTHERA Biopharmaceuticals Announces Positive Results From Two Phase 2 Studies With ATX-101 Demonstrating Reduction Of Submental Fat

KYTHERA Biopharmaceuticals, Inc. (KYTHERA) announced that it has successfully completed two Phase 2 clinical studies demonstrating the efficacy, safety, and tolerability of its lead product candidate, ATX-101, for the reduction of submental ('under-the-chin') fat.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

Mortality And Cancer Risks For Radiation Workers

The risk of developing cancer among radiation workers increases with the dose of ionising radiation they are exposed to, according to a study by the Health Protection Agency published today in the British Journal of Cancer *. The observed cancer risks are consistent with the international scientific consensus on radiation protection.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

Early Plans For The Roll Out Of Individual Health Record Approved

Information will help clinicians speed up diagnosis Plans to roll-out a system that will enable clinicians in hospital emergency departments and out-of-hours GPs to have access to important patient information to help with diagnosis and treatment have been approved by Health Minister Edwina Hart today.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

New Blog On Social Care And Palliative Care, UK

A new blog has been launched, by St Christopher's Hospice policy and development adviser, Malcolm Payne. It aims to keep social care professionals in touch with end-of-life care issues and raise awareness and understanding social care among palliative care professionals.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

University Lecturer Warns Of Rising Prevalence Of Type 2 Diabetes, UK

With the New Year inevitably comes the resolution of millions to get in shape. But shedding the pounds is now more important than ever - being overweight is the top factor in developing Type 2 diabetes.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

MS Trust Given The Gift Of Radio Advertising, UK

Passion for the Planet, the UK's only radio station focused on helping people live a greener, healthier more ethical life has celebrated its sixth birthday by choosing charities to benefit from a free advertising campaign.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Hard link

Palonosetron Used With Dexamethasone Is Effective At Preventing Nausea And Vomiting After Chemotherapy

Palonosetron is as effective as, and in some ways better than, granisetron in preventing the nausea and vomiting that is often experienced after highly emetogenic chemotherapy, conclude the authors of a phase III comparator trial that is published in an Article Online first and in the February edition of The Lancet Oncology.

Worst - 1

1
2
3
4
5

Best - 5

08.01.2009 14:00:00 - Health News from Medical News Today

Latest news

ArGentis Receives Favorable Opinion For European Orphan Drug Designation

Cytori Expands Patent Protection For Celution(R) Stem & Regenerative Cell Processing System

Genetics For The Public: First Annual Consumer Genetics Show In Boston June 9 -11, 2009

KYTHERA Biopharmaceuticals Announces Positive Results From Two Phase 2 Studies With ATX-101 Demonstrating Reduction Of Submental Fat

Mortality And Cancer Risks For Radiation Workers

Early Plans For The Roll Out Of Individual Health Record Approved

New Blog On Social Care And Palliative Care, UK

University Lecturer Warns Of Rising Prevalence Of Type 2 Diabetes, UK

MS Trust Given The Gift Of Radio Advertising, UK

Palonosetron Used With Dexamethasone Is Effective At Preventing Nausea And Vomiting After Chemotherapy

RSS sources

Your own sources

Public sources